Paradigm Shift in the Management of Acute Myeloid Leukemia—Approved Options in 2023

SIMPLE SUMMARY: Acute Myeloid Leukemia is the most common aggressive blood cancer in adults. Treatment for this condition is divided into induction followed by consolidation. The mainstay of treatment is chemotherapy, and until a decade ago, only traditional chemotherapy was approved for this condit...

Descripción completa

Detalles Bibliográficos
Autores principales: Premnath, Naveen, Madanat, Yazan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251983/
https://www.ncbi.nlm.nih.gov/pubmed/37296964
http://dx.doi.org/10.3390/cancers15113002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251983/
https://www.ncbi.nlm.nih.gov/pubmed/37296964
http://dx.doi.org/10.3390/cancers15113002

Ejemplares similares